Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Wiersinga, WJ"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 52
Tytuł:
Impact of Blood Culture Contamination on Antibiotic Use, Resource Utilization, and Clinical Outcomes: A Retrospective Cohort Study in Dutch and US Hospitals.
Autorzy:
Schinkel M; Center for Experimental and Molecular Medicine, Amsterdam UMC, Location Academic Medical Center, Amsterdam, the Netherlands.; Division of Acute Medicine, Department of Internal Medicine, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Boerman A; Division of Acute Medicine, Department of Internal Medicine, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Carroll K; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Cosgrove SE; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Hsu YJ; Department of Health Policy and Management, Johns Hopkins Bloomberg of School of Public Health, Baltimore, Maryland, USA.
Klein E; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Center for Disease Dynamics, Economics & Policy, Washington, DC, USA.
Nanayakkara P; Division of Acute Medicine, Department of Internal Medicine, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Schade R; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Amsterdam, the Netherlands.
Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam UMC, Location Academic Medical Center, Amsterdam, the Netherlands.; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, Location Academic Medical Center, Amsterdam, the Netherlands.
Fabre V; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Dec 22; Vol. 11 (2), pp. ofad644. Date of Electronic Publication: 2023 Dec 22 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Graphical Overview of the Histopathology of Human Melioidosis: A Case Series.
Autorzy:
Savelkoel J; Center for Experimental and Molecular Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, the  Netherlands.
Tiemensma M; Territory Pathology, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Birnie E; Center for Experimental and Molecular Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, the  Netherlands.
Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, the  Netherlands.; Division of Infectious Diseases, Amsterdam UMC location University of Amsterdam, Amsterdam, the  Netherlands.
Currie BJ; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.; Infectious Diseases Department, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Roelofs JJTH; Department of Pathology, Amsterdam UMC location University of Amsterdam, Amsterdam, the  Netherlands.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Jul 12; Vol. 10 (8), pp. ofad367. Date of Electronic Publication: 2023 Jul 12 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Embracing cohort heterogeneity in clinical machine learning development: a step toward generalizable models.
Autorzy:
Schinkel M; Center for Experimental and Molecular Medicine (CEMM), Location Academic Medical Center, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. .
Bennis FC; Quantitative Data Analytics Group, Department of Computer Science, Vrije Universiteit Amsterdam, De Boelelaan 1105, Amsterdam, The Netherlands.
Boerman AW; Department of Internal Medicine, Section General Internal Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Wiersinga WJ; Department of Internal Medicine, Amsterdam UMC University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Nanayakkara PWB; Department of Internal Medicine, Section General Internal Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 24; Vol. 13 (1), pp. 8363. Date of Electronic Publication: 2023 May 24.
Typ publikacji:
Journal Article
MeSH Terms:
Machine Learning*
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Presence of Burkholderia pseudomallei in Soil, Nigeria, 2019.
Autorzy:
Savelkoel J
Oladele RO
Ojide CK
Peters RF
Notermans DW
Makinwa JO
de Vries MC
Sunter MAE
Matamoros S
Abdullahi N
Unigwe US
Akanmu AS
Wiersinga WJ
Birnie E
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2023 May; Vol. 29 (5), pp. 1073-1075.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Burkholderia pseudomallei*/genetics
Melioidosis*/epidemiology
Melioidosis*/microbiology
Humans ; Nigeria/epidemiology ; Soil Microbiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Real-world Evidence of the Effects of Novel Treatments for COVID-19 on Mortality: A Nationwide Comparative Cohort Study of Hospitalized Patients in the First, Second, Third, and Fourth Waves in the Netherlands.
Autorzy:
Slim MA; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; Department of Intensive Care, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
Appelman B; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
Peters-Sengers H; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; Department of Epidemiology and Data Science, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
Dongelmans DA; Department of Intensive Care, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; National Intensive Care Evaluation (NICE) Foundation, Amsterdam, the Netherlands.
de Keizer NF; National Intensive Care Evaluation (NICE) Foundation, Amsterdam, the Netherlands.; Department of Medical Informatics, Amsterdam University Medical Centers, University of Amsterdam-Location AMC, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
Schade RP; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam, the Netherlands.
de Boer MGJ; Department of Infectious Diseases and Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Müller MCA; Department of Intensive Care, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
Vlaar APJ; Department of Intensive Care, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam, the Netherlands.
van Vught LA; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; Department of Intensive Care, Amsterdam University Medical Centers-Location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
Pokaż więcej
Corporate Authors:
NICE COVID-19 Research Consortium and the COVIDPredict study group
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Nov 22; Vol. 9 (12), pp. ofac632. Date of Electronic Publication: 2022 Nov 22 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults.
Autorzy:
Sieswerda E; Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands. .; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. .
Bax HI; Department of Internal Medicine, Section of Infectious Diseases and Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
Hoogerwerf JJ; Department of Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
de Boer MGJ; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Boermeester M; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Bonten MJM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Dekker D; Department of Internal Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
van Wijk RG; Division of Allergology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Juffermans NP; Department of Intensive Care, OLVG Hospital, Amsterdam, The Netherlands.
Kuindersma M; Department of Intensive Care, Gelre ziekenhuis Apeldoorn, Apeldoorn, The Netherlands.
van der Linden PD; Department of Clinical Pharmacy, Tergooi Hospital, Hilversum, The Netherlands.
Melles DC; Department of Medical Microbiology and Immunology, Meander Medical Center, Amersfoort, The Netherlands.
Pickkers P; Department of Intensive Care Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Schouten JA; Department of Intensive Care Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Rebel JR; Department of Emergency Medicine, OLVG Hospital, Amsterdam, The Netherlands.
van Zanten ARH; Department of Intensive Care Medicine, Ziekenhuis Gelderse Vallei, Ede, The Netherlands.
Prins JM; Division of Infectious Diseases, Department of Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Wiersinga WJ; Division of Infectious Diseases, Department of Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2022 Aug 11; Vol. 22 (1), pp. 687. Date of Electronic Publication: 2022 Aug 11.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Bacterial Agents*/therapeutic use
Sepsis*/drug therapy
Adult ; Humans ; Netherlands ; Policy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association between dexamethasone treatment and the host response in COVID-19 patients admitted to the general ward.
Autorzy:
de Brabander J; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Meibergdreef 9, Amsterdam, The Netherlands. .
Michels EHA; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Meibergdreef 9, Amsterdam, The Netherlands.
van Linge CCA; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Meibergdreef 9, Amsterdam, The Netherlands.
Chouchane O; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Meibergdreef 9, Amsterdam, The Netherlands.
Douma RA; Department of Internal Medicine, Flevo Hospital, Almere, The Netherlands.
Reijnders TDY; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Meibergdreef 9, Amsterdam, The Netherlands.
Schuurman AR; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Meibergdreef 9, Amsterdam, The Netherlands.
van Engelen TSR; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Meibergdreef 9, Amsterdam, The Netherlands.
Wiersinga WJ; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Meibergdreef 9, Amsterdam, The Netherlands.
van der Poll T; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Meibergdreef 9, Amsterdam, The Netherlands.
Pokaż więcej
Corporate Authors:
Amsterdam UMC COVID-19 biobank study group
Źródło:
Respiratory research [Respir Res] 2022 Jun 03; Vol. 23 (1), pp. 145. Date of Electronic Publication: 2022 Jun 03.
Typ publikacji:
Letter
MeSH Terms:
COVID-19 Drug Treatment*
Biomarkers ; Dexamethasone/therapeutic use ; Humans ; Patients' Rooms
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mortality and readmission rates among hospitalized COVID-19 patients with varying stages of chronic kidney disease: a multicenter retrospective cohort.
Autorzy:
Appelman B; Center for Experimental and Molecular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.; The Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.
Oppelaar JJ; Department of Internal Medicine, Section of Nephrology, Amsterdam UMC, Amsterdam, The Netherlands.
Broeders L; Department of Internal Medicine, Section of Nephrology, Amsterdam UMC, Amsterdam, The Netherlands.
Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.; The Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.; Division of Infectious Diseases, Location Academic Medical Center, University of Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Peters-Sengers H; Center for Experimental and Molecular Medicine, Amsterdam UMC, Amsterdam, The Netherlands.; The Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.
Vogt L; Department of Internal Medicine, Section of Nephrology, Amsterdam UMC, Amsterdam, The Netherlands. .
Pokaż więcej
Corporate Authors:
CovidPredict Study Group
Źródło:
Scientific reports [Sci Rep] 2022 Feb 10; Vol. 12 (1), pp. 2258. Date of Electronic Publication: 2022 Feb 10.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19/*mortality
Patient Readmission/*statistics & numerical data
Renal Insufficiency, Chronic/*complications
Aged ; COVID-19/complications ; Female ; Humans ; Male ; Middle Aged ; Netherlands/epidemiology ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An epigenetic and transcriptomic signature of immune tolerance in human monocytes through multi-omics integration.
Autorzy:
Brands X; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands. .
Haak BW; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.
Klarenbeek AM; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.
Butler J; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.
Uhel F; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.
Qin W; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.
Otto NA; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.
Jakobs ME; Laboratory of Genome Analysis, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.
Faber DR; BovenIJ hospital, Amsterdam, 1034, CS, the Netherlands.
Lutter R; Respiratory Medicine and Experimental Immunology, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.
Wiersinga WJ; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.; Division of Infectious Diseases, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.
van der Poll T; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.; Division of Infectious Diseases, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.
Scicluna BP; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands. .; Department of Applied Biomedical Sciences, Faculty of Health Sciences, Mater Dei Hospital, University of Malta, Msida, Malta. .; Centre for Molecular Medicine and Biobanking, University of Malta, Msida, Malta. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2021 Aug 16; Vol. 13 (1), pp. 131. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Epigenesis, Genetic*
Epigenomics*/methods
Gene Expression Regulation*
Transcriptome*
Immune Tolerance/*genetics
Monocytes/*immunology
Monocytes/*metabolism
Comorbidity ; Computational Biology/methods ; Cytokines/genetics ; Cytokines/metabolism ; Female ; High-Throughput Nucleotide Sequencing ; Humans ; Inflammation Mediators/metabolism ; Male ; Sequence Analysis, DNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pulmonary and intestinal microbiota dynamics during Gram-negative pneumonia-derived sepsis.
Autorzy:
Wolff NS; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Jacobs MC; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. w.j.wiersinga@amsterdamumc.nl.; Department of Medicine, Division of Infectious Diseases, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. w.j.wiersinga@amsterdamumc.nl.
Hugenholtz F; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Intensive care medicine experimental [Intensive Care Med Exp] 2021 Jul 12; Vol. 9 (1), pp. 35. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sepsis: deriving biological meaning and clinical applications from high-dimensional data.
Autorzy:
Schuurman AR; Center for Experimental and Molecular Medicine, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands.
Reijnders TDY; Center for Experimental and Molecular Medicine, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands.
Kullberg RFJ; Center for Experimental and Molecular Medicine, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands.
Butler JM; Center for Experimental and Molecular Medicine, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands.
van der Poll T; Center for Experimental and Molecular Medicine, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands.
Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands. w.j.wiersinga@amsterdamumc.nl.; Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Noord-Holland, Amsterdam, 1105 AZ, The Netherlands. w.j.wiersinga@amsterdamumc.nl.
Pokaż więcej
Źródło:
Intensive care medicine experimental [Intensive Care Med Exp] 2021 May 07; Vol. 9 (1), pp. 27. Date of Electronic Publication: 2021 May 07.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effect of antibiotic gut microbiota disruption on LPS-induced acute lung inflammation.
Autorzy:
Jacobs MC; Center for Experimental and Molecular Medicine, Amsterdam UMC, Location Academic Medical Center (AMC), Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.
Lankelma JM; Center for Experimental and Molecular Medicine, Amsterdam UMC, Location Academic Medical Center (AMC), Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.
Wolff NS; Center for Experimental and Molecular Medicine, Amsterdam UMC, Location Academic Medical Center (AMC), Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.
Hugenholtz F; Center for Experimental and Molecular Medicine, Amsterdam UMC, Location Academic Medical Center (AMC), Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.
de Vos AF; Center for Experimental and Molecular Medicine, Amsterdam UMC, Location Academic Medical Center (AMC), Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.
van der Poll T; Center for Experimental and Molecular Medicine, Amsterdam UMC, Location Academic Medical Center (AMC), Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Medicine, Amsterdam UMC, Location Academic Medical Center (AMC), Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.
Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam UMC, Location Academic Medical Center (AMC), Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Medicine, Amsterdam UMC, Location Academic Medical Center (AMC), Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Nov 04; Vol. 15 (11), pp. e0241748. Date of Electronic Publication: 2020 Nov 04 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Acute Lung Injury/*etiology
Anti-Bacterial Agents/*pharmacology
Gastrointestinal Microbiome/*drug effects
Lipopolysaccharides/*toxicity
Animals ; Bronchoalveolar Lavage Fluid/chemistry ; Female ; Interleukin-6/metabolism ; Lung/pathology ; Mice ; Mice, Inbred C57BL
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.
Autorzy:
Birnie E
Koh GCKW
Löwenberg EC
Meijers JCM
Maude RR
Day NPJ
Peacock SJ
van der Poll T
Wiersinga WJ
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Sep 01; Vol. 14 (9), pp. e0008722. Date of Electronic Publication: 2020 Sep 01 (Print Publication: 2020).
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Vendor effects on murine gut microbiota and its influence on lipopolysaccharide-induced lung inflammation and Gram-negative pneumonia.
Autorzy:
Wolff NS; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands.
Jacobs MC; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands.
Haak BW; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands.
Roelofs JJTH; Department of Pathology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands.
de Vos AF; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands.
Hugenholtz F; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands.
Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands. w.j.wiersinga@amsterdamumc.nl.; Department of Medicine, Division of Infectious Diseases, Amsterdam UMC, location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands. w.j.wiersinga@amsterdamumc.nl.
Pokaż więcej
Źródło:
Intensive care medicine experimental [Intensive Care Med Exp] 2020 Aug 25; Vol. 8 (1), pp. 47. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.
Autorzy:
Brouwer PJM; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Caniels TG; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
van der Straten K; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.; Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Snitselaar JL; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Aldon Y; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bangaru S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Okba NMA; Department of Viroscience, Erasmus Medical Center, Rotterdam, 3015GD, Netherlands.
Claireaux M; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Kerster G; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bentlage AEH; Sanquin Research, Department of Experimental Immunohematology, Amsterdam, Netherlands and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1006AD Amsterdam, Netherlands.
van Haaren MM; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Guerra D; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Burger JA; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Schermer EE; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Verheul KD; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
van der Velde N; IBIS Technologies BV, 7521PR Enschede, Netherlands.
van der Kooi A; IBIS Technologies BV, 7521PR Enschede, Netherlands.
van Schooten J; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
van Breemen MJ; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bijl TPL; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Sliepen K; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Aartse A; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.; Department of Virology, Biomedical Primate Research Centre, 2288GJ Rijswijk, Netherlands.
Derking R; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bontjer I; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Kootstra NA; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Wiersinga WJ; Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Vidarsson G; Sanquin Research, Department of Experimental Immunohematology, Amsterdam, Netherlands and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1006AD Amsterdam, Netherlands.
Haagmans BL; Department of Viroscience, Erasmus Medical Center, Rotterdam, 3015GD, Netherlands.
Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
de Bree GJ; Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands. .
Sanders RW; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands. .; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA.
van Gils MJ; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands. .
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2020 Aug 07; Vol. 369 (6504), pp. 643-650. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal/*immunology
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
Betacoronavirus/*immunology
Coronavirus Infections/*immunology
Pneumonia, Viral/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Adult ; Aged ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Antibody Affinity ; Antigens, Viral/immunology ; B-Lymphocyte Subsets/immunology ; Broadly Neutralizing Antibodies/immunology ; COVID-19 ; Cell Line, Tumor ; Coronavirus Infections/prevention & control ; Coronavirus Infections/therapy ; Epitopes/immunology ; Female ; Humans ; Immunologic Memory ; Immunophenotyping ; Male ; Middle Aged ; Pandemics/prevention & control ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/therapy ; Protein Domains ; Protein Interaction Domains and Motifs/immunology ; Receptors, Coronavirus ; Receptors, Virus/metabolism ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Altered Patterns of Compositional and Functional Disruption of the Gut Microbiota in Typhoid Fever and Nontyphoidal Febrile Illness.
Autorzy:
Haak BW; Center for Experimental and Molecular Medicine (CEMM), Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.
de Jong HK; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.
Kostidis S; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
Giera M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
Maude RR; Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Samad R; Chittagong Medical College Hospital, Chittagong, Bangladesh.
Wijedoru L; Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Ghose A; Chittagong Medical College Hospital, Chittagong, Bangladesh.
Faiz MA; Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Dev Care Foundation, Dhaka, Bangladesh.
Parry CM; Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; Institute of Infection and Global Health, University of Liverpool, United Kingdom.; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
Wiersinga WJ; Center for Experimental and Molecular Medicine (CEMM), Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Jun 26; Vol. 7 (7), pp. ofaa251. Date of Electronic Publication: 2020 Jun 26 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of host immune responses to LPS in human using an immune profiling panel, in vivo endotoxemia versus ex vivo stimulation.
Autorzy:
Tawfik DM; EA7426 'Pathophysiology of Injury-Induced Immunosuppression', PI3, Université Claude Bernard Lyon-1 Hospices Civils de Lyon - bioMérieux, Lyon, France.; Open Innovation and Partnerships (OIP), bioMérieux S.A, Lyon, France.
Lankelma JM; Center for Experimental and Molecular Medicine, Amsterdam UMC, location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Vachot L; Open Innovation and Partnerships (OIP), bioMérieux S.A, Lyon, France.; Department of Medical Microbiology and Infection Control, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Cerrato E; Open Innovation and Partnerships (OIP), bioMérieux S.A, Lyon, France.; Department of Medical Microbiology and Infection Control, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Pachot A; Department of Medical Microbiology and Infection Control, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Wiersinga WJ; Division of Infectious Diseases, Department of Medicine, Amsterdam UMC, location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Anaesthesia and Critical Care Medicine Department, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
Textoris J; Open Innovation and Partnerships (OIP), bioMérieux S.A, Lyon, France. .; Department of Medical Microbiology and Infection Control, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. .; Anaesthesia and Critical Care Medicine Department, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Jun 18; Vol. 10 (1), pp. 9918. Date of Electronic Publication: 2020 Jun 18.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers/*blood
Endotoxemia/*blood
Endotoxemia/*immunology
Immunity, Innate/*immunology
Lipopolysaccharides/*pharmacology
Monocytes/*metabolism
Transcriptome/*drug effects
Adolescent ; Adult ; Endotoxemia/chemically induced ; Endotoxemia/pathology ; Female ; Humans ; Immunity, Innate/drug effects ; Male ; Middle Aged ; Monocytes/drug effects ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 52

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies